No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Vor Biopharma's Chief Medical Officer Resigns
Here's Why Vor Biopharma (NASDAQ:VOR) Must Use Its Cash Wisely
JMP Securities Maintains Vor Biopharma(VOR.US) With Buy Rating, Maintains Target Price $6
Optimistic Buy Rating for Vor Biopharma Amid Promising Clinical Developments and Stable Financial Position
Wedbush Maintains Vor Biopharma(VOR.US) With Buy Rating, Cuts Target Price to $7
Oppenheimer Reiterates Outperform on Vor Biopharma, Maintains $8 Price Target
